Niagen Bioscience Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio47.50
Forward P/E50.28
P/S Ratio4.081.291.743.795.02
P/B Ratio8.813.784.378.0618.11
Price/Tangible Book8.883.854.488.2919.39
Price/FCF33.9915.45
Price/OCF33.5415.13
Enterprise Value Ratios
EV/Revenue3.781.011.623.354.79
EV/EBITDA44.12
EV/EBIT48.76
EV/FCF31.5412.17
Profitability & Returns
Return on Equity (ROE)0.23%-0.17%-0.55%-1.13%-1.08%
Return on Assets (ROA)0.08%-0.06%-0.21%-0.35%-0.32%
Return on Invested Capital (ROIC)1.70%-0.65%-1.77%-5.43%-7.76%
Return on Capital Employed (ROCE)0.15%-0.16%-0.52%-0.67%-0.91%
Leverage & Solvency Ratios
Debt/Equity0.060.120.150.150.10
Debt/EBITDA0.27
Debt/FCF0.220.47
Liquidity Ratios
Current Ratio3.572.402.612.781.96
Quick Ratio2.961.571.611.891.17
Efficiency Ratios
Asset Turnover1.621.531.291.401.51
Inventory Turnover3.212.252.072.052.07
Yield & Distribution Ratios
Earnings Yield0.02%-0.05%-0.13%-0.11%-0.07%
FCF Yield0.03%0.06%-0.12%-0.10%-0.04%
Buyback Yield-0.04%-0.08%-0.04%-0.10%-0.07%